S19 Novel Mechanisms for Protection of Beta Cell Mass

Program: Symposia
Basic/Translational Session
Friday, April 1, 2016: 4:45 PM-6:15 PM
Room 156 (BCEC)
Gordon C. Weir, MD, Joslin Diabetes Center/Harvard Medical School, Boston, MA

Nothing to Disclose: GCW
4:45 PM
Ernesto Bernal-Mizrachi, MD, University of Michigan Comprehensive Diabetes Center, Ann Arbor, MI
Nothing to Disclose: EB
5:15 PM
Senta Georgia, PhD, Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA
Nothing to Disclose: SG
5:45 PM
Mehboob Ali Hussain, MD, Metabolism Division, Johns Hopkins University School of Medicine, Baltimore, MD
Nothing to Disclose: MAH
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire